How do I verify the COA?
Every batch is independently tested by Janoshik Analytical. Each product links straight to the lab's own record, so you can check the exact purity figure yourself before you buy — nothing to take on trust.

Format
Sealed research vial
Trust signal
COA-backed inventory
Recovery & Repair · Research grade
Lab-grade supply. Stocked in Australia.
From A$109.99
Select options below
Size
Select one
Select your preferred options to continue.
Volume pricing: orders of 3+ items are 15% off — applied automatically at checkout.
Third-party tested · 99%+ purity · Dispatched from Melbourne within 1 business day · 4.6★ on Trustpilot
Fast AU dispatch, tracked delivery, and documentation-ready inventory.
Why labs buy from APL
High purity, consistent supply, and fast AU-wide dispatch.
Certificate of Analysis
Certificate of Analysis
Verified purity: 99.546%
BPC-157 + TB-500
COA-backed · third-party tested
Structural class
BPC-157 + TB-500 is a research panel pairing BPC-157 with the thymosin β4 fragment TB-500, studied together in cell-migration, matrix-remodelling, and angiogenic-signalling assay models.
Pathways studied
BPC-157 is a 15-amino acid pentadecapeptide derived from the partial sequence of human gastric juice protein BPC; in cell-based models it has been studied for interactions with NO/eNOS signalling, VEGFR2-mediated angiogenic pathways, and focal adhesion kinase (FAK)/paxillin complexes relevant to cell-migration assays. TB-500 corresponds to the active fragment of thymosin β4 containing the actin-sequestering LKKTET motif; it binds G-actin with high affinity, reduces the G/F-actin ratio, and modulates cell migration and angiogenesis signalling in scratch-assay models.
Typical research focus
Research panels combining these two peptides often examine matrix remodelling and angiogenic marker expression under well-defined in vitro conditions. Because BPC-157 and TB-500 operate via distinct molecular targets, selectivity controls and appropriate receptor antagonists are important experimental design considerations when the two are studied in parallel.
For laboratory research use only. Not for human or veterinary use, and not for human consumption. Intended for in-vitro and pre-clinical research settings only.
How to read a certificate of analysis, what purity actually measures, and how research peptides are stored and independently verified.
The questions researchers ask most.
Every batch is independently tested by Janoshik Analytical. Each product links straight to the lab's own record, so you can check the exact purity figure yourself before you buy — nothing to take on trust.
Keep vials sealed, dry, and out of direct light. Lyophilised (freeze-dried) peptides are stable at -20 °C; once reconstituted, store as noted on the product label. Full handling notes sit on every product page.
Order by 2pm for same-day dispatch from our Melbourne warehouse, otherwise the next business day, with tracked delivery Australia-wide. No customs, no border delays — it's already in the country.
More in the full FAQ · Rated 4.6★ on Trustpilot
Researchers who bought BPC-157 + TB-500 also stock these.
It brings together 2 labelled variants: 20mg and 10mg, current pricing context, stock visibility, COA access, and internal links to related catalogue pages so a laboratory buyer can review the material from a single reference URL.
BPC-157 + TB-500 is generally discussed as a research panel pairing BPC-157 with the thymosin β4 fragment TB-500, studied together in cell-migration, matrix-remodelling, and angiogenic-signalling assay models. The most relevant background is sequence behaviour, pathway or receptor context where documented, and analytical consistency under controlled laboratory conditions.
Use the label, COA, and internal SOPs as the primary guide. In general, store the material under controlled laboratory conditions, minimise avoidable environmental exposure, and keep variant tracking records current.
Yes. This listing includes access to a product-specific COA, which should be reviewed before use so purity, identity, and documentation checks are aligned with the project record.
No. The page should be interpreted strictly in a research and laboratory context. It does not provide dosage guidance, treatment claims, or human or animal use instructions.